Sometimes the most ordinary things in a medical cabinet turn out to hold an unexpected promise. A gas long familiar from dental chairs and delivery rooms may, in the right dose, lift the weight of severe depression within a day, as a new University of Birmingham analysis suggests. For the many people for whom existing antidepressants bring little or no relief, that possibility carries real meaning, even as the researchers are careful to note that the lightness fades within a week. The finding is less a conclusion than an opening, a question about whether a brief reprieve can become something t
Laughing Gas Shows Rapid Antidepressant Effect in Study, But Relief Is Short-Lived
Relief within 24 hours, gone within a week
Mark
So what actually did the researchers find?
Mimi
That a single session of 50 percent nitrous oxide reduced depression symptoms within 24 hours in adults with treatment-resistant depression and major depressive disorder.
Mark
And why does speed matter so much here?
Mimi
Gill's point is that antidepressants make no meaningful difference for almost half of patients. A treatment that works in a day is a different proposition from one that takes a while and may not work at all.
Luke
But the relief faded within a week. That's not a small caveat.
Mimi
No, it isn't. Repeated inhalation tended to give more lasting results, though.
Luke
"Tended to" is carrying a lot. The report doesn't say how many sessions, how often, or how long the benefit lasted. Those are unknowns here.
Mark
Is this a new clinical trial, then?
Mimi
It's an analysis that pulls together existing clinical data, published in eBioMedicine. The NHS trial is still planned, not underway.
Luke
Worth noting too that the claim of a breakthrough comes from the coverage's framing. The researchers themselves are asking for longer trials to test durability.
Mark
So what should a reader watch for?
Mimi
Whether the NHS trial starts, and whether longer studies show the effect can be sustained.
Il Polso
- Nearly half of people diagnosed with depression see no meaningful benefit from antidepressants, leaving a painful gap in care.
- A single 50 percent nitrous oxide session eased depressive symptoms within 24 hours, offering urgent hope where little was available.
- The relief proved fleeting, slipping away within a week and forcing researchers to confront the limits of a one-time fix.
- Repeated sessions appear to produce steadier results, and the team is moving to test this in a first NHS trial in the UK.
- Longer studies must now determine whether the benefit can be sustained, and the outcome remains open.
Sometimes the most ordinary things in a medical cabinet turn out to hold an unexpected promise. A gas long familiar from dental chairs and delivery rooms may, in the right dose, lift the weight of severe depression within a day, as a new University of Birmingham analysis suggests. For the many people for whom existing antidepressants bring little or no relief, that possibility carries real meaning, even as the researchers are careful to note that the lightness fades within a week. The finding is less a conclusion than an opening, a question about whether a brief reprieve can become something that lasts.
Inhale a 50 percent mix of nitrous oxide, the gas many people know from the dentist's chair, and within a day the heaviness of severe depression may begin to lift. That is the central finding of a new analysis from the University of Birmingham, published in eBioMedicine. The team drew together clinical data on adults with treatment-resistant depression and major depressive disorder. Nitrous oxide is already used as a pain reliever, and earlier studies had hinted at fast-acting antidepressant effects. This work gathers that evidence in one place.
The results are clear but limited. One session brought significant reductions in symptoms within a day, yet by the end of a week the relief had faded. Repeated sessions tended to produce more lasting results, though the details of how many and over what period remain unspecified.
Kiranpreet Gill, the PhD researcher who led the analysis, pointed to a hard truth about current care: antidepressants make no meaningful difference for almost half the people who take them. That gap is what makes a rapid option so compelling. She stressed the word short-term, calling for longer trials to learn whether the benefit can endure.
The team is preparing to begin the first NHS trial of the treatment in the United Kingdom, testing whether nitrous oxide could become a fast-acting therapy for severe depression. For now, the picture is of a real but brief effect, with repeated dosing looking more promising. Whether that holds over time is the question the coming studies must answer.
Inhale a 50 percent concentration of nitrous oxide, the gas many people know from dental chairs and delivery rooms, and within 24 hours the symptoms of severe depression may ease. That is the central finding of a new analysis from the University of Birmingham, published in the journal eBioMedicine.
The work was led by a team at Birmingham and draws together clinical data on medically administered nitrous oxide in adults with two conditions: treatment-resistant depression, known as TRD, and major depressive disorder, or MDD. Nitrous oxide is already used in medicine as a pain reliever. Several earlier studies have linked it to fast-acting antidepressant effects, and this analysis gathers the evidence in one place.
What the data show is a clear but limited result. A single session of 50 percent nitrous oxide produced significant reductions in depressive symptoms within a day. But the relief did not last. By the end of a week it had faded. Repeated inhalation, by contrast, tended to produce more sustained results, though the source does not specify how many sessions or over what period.
Kiranpreet Gill, a PhD researcher at the University of Birmingham and first author of the analysis, framed the work against a hard fact about current care. Depression is a debilitating illness, she said, made harder by the fact that antidepressants make no meaningful difference for almost half of the patients diagnosed with it. That gap is what makes a fast-acting option interesting to researchers.
Gill said the study brings together the best available evidence that nitrous oxide could deliver swift and clinically significant short-term improvement in people with severe depression. She described it as part of a new generation of rapid-acting treatments. Her emphasis, though, was on the word short-term: she called for longer trials to find out whether the benefit can be maintained over time.
The team is not waiting idly for that. Given the results so far, the researchers are ready to begin their first National Health Service trial in the United Kingdom. Its aim is to test whether nitrous oxide could become the next fast-acting treatment for severe clinical depression.
For now, the picture is of a fast, real, but brief effect, with repeated dosing looking more promising than a single one. Whether that holds up over longer periods is the question the planned NHS trial and any longer studies will have to answer.
Citazioni salienti
Antidepressants make no meaningful difference for almost half of all patients diagnosed with depression.— Kiranpreet Gill, PhD researcher, University of Birmingham
Nitrous oxide is part of a new generation of rapid-acting treatments, and longer trials are needed to assess long-term efficacy.— Kiranpreet Gill (paraphrased)
Vuoi la storia completa?
Leggi l'originale su The News International ↗
Health & Medicine